US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Generate Biomedicines

12.26

-1.5850-11.45%

Post-market: 12.870.6157+5.02%19:59 EDT

Volume:937.75K

Turnover:11.88M

Market Cap:1.57B

PE:-3.74

High:13.75

Open:13.75

Low:12.25

Close:13.84

52wk High:22.67

52wk Low:11.00

Shares:128.19M

Float Shares:60.29M

Volume Ratio:0.97

T/O Rate:1.56%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2762

EPS(LYR):-4.9816

ROE:-81.72%

ROA:-34.63%

PB:3.44

PE(LYR):-2.46

Loading ...

Overview Company News Filings

Generate Biomedicines, Zealand Pharma enter protein therapeutics pact

Zealand Pharma Partners with Generate Biomedicines on AI-Designed Protein Therapeutics for Metabolic Diseases

Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases

THOMSON REUTERS

Generate Biomedicines - to Receive $30 Mln Upfront, up to $1.20 Bln in Milestones, Plus Royalties

THOMSON REUTERS

Generate Biomedicines - Co to Lead Research; Zealand Pharma to Handle Clinical Development and Commercialization

THOMSON REUTERS

Generate Biomedicines - to Lead Research; Zealand Pharma to Handle Clinical Development and Commercialization

THOMSON REUTERS

Zealand Pharma, Generate Strike Obesity Drug Deal Worth up to $1.2 Billion, Bloomberg News Reports

Zealand Pharma Makes Deal with Generate Worth up to $1.2 Billion - Bloomberg News

THOMSON REUTERS

Generate Biomedicines Price Target Maintained with a $30.00/Share by HC Wainwright & Co.

Seven new option listings on October 2nd

Analysts Are Bullish on Top NA Stocks: Generate Biomedicines, Inc. (GENB), Netskope, Inc. (NTSK)

Generate Biomedicines - Gb-5267 Targets Muc16 Biomarker in over 80% of Ovarian Tumors

THOMSON REUTERS

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ Car T Therapy for Ovarian Cancer

THOMSON REUTERS

Generate Biomedicines - Gb-5267 Treatment Designed to Avoid Pre-Infusion Chemotherapy

THOMSON REUTERS

Generate Biomedicines Price Target Maintained with a $30.00/Share by HC Wainwright & Co.

Generate Biomedicines Management to Present at Upcoming Investor Conferences

Generate Biomedicines Director Frances Arnold Sells USD 16,002 of Common Shares

Generate Biomedicines is Maintained at Buy by HC Wainwright & Co.

U.S. Research Roundup-Dollar General, Palo Alto, Workday

Small U.S. Stocks Finish Mixed as Abercrombie & Fitch Leads, Generate Biomedicines Lags

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketb.com/stock/GENB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GENB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","market":"US","secType":"STK","nameCN":"Generate Biomedicines","latestPrice":12.255,"timestamp":1791921600000,"preClose":13.84,"halted":0,"volume":937753,"hourTrading":{"tag":"盘后","latestPrice":12.8707,"preClose":12.255,"latestTime":"19:59 EDT","volume":30127,"amount":381835.9765,"timestamp":1791935981586,"change":0.6157,"changeRate":0.050241,"amplitude":0.052379},"delay":0,"changeRate":-0.11452312138728317,"floatShares":60288200,"shares":128192484,"eps":-3.27625,"marketStatus":"Not Yet Opened","change":-1.585,"latestTime":"10-13 16:00:00 EDT","open":13.75,"high":13.75,"low":12.25,"amount":11876307.904932,"amplitude":0.108382,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.27625,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":0,"adr":0,"listingDate":1772168400000,"exchange":"NASDAQ","adjPreClose":13.84,"preHourTrading":{"tag":"盘前","latestPrice":13.95,"preClose":13.84,"latestTime":"09:18 EDT","volume":362,"amount":4989.35007,"timestamp":1791897499798,"change":0.11,"changeRate":0.007948,"amplitude":0.014451},"postHourTrading":{"tag":"盘后","latestPrice":12.8707,"preClose":12.255,"latestTime":"19:59 EDT","volume":30127,"amount":381835.9765,"timestamp":1791935981586,"change":0.6157,"changeRate":0.050241,"amplitude":0.052379},"volumeRatio":0.9704222656808936,"impliedVol":0.7743,"impliedVolPercentile":0.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","floatShares":60288200,"roa":"-34.63%","roe":"-81.72%","lyrEps":-4.981642,"volumeRatio":0.970422,"shares":128192484,"dividePrice":0,"high":13.75,"amplitude":0.108382,"preClose":13.84,"low":12.25,"week52Low":11,"pbRate":"3.44","psRate":"59.32","week52High":22.6699,"institutionHeld":0,"latestPrice":12.255,"eps":-3.27625,"divideRate":0,"volume":937753,"delay":0,"ttmEps":-3.27625,"open":13.75,"prevYearClose":16,"prevWeekClose":14.34,"prevMonthClose":15.02,"prevQuarterClose":15.02,"fiveDayClose":13.8,"twentyDayClose":16.19,"sixtyDayClose":13.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GENB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"GENB","fiscalQuarterEnding":"2026/06","expectedEps":-0.48,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2026-05-07","symbol":"GENB","fiscalQuarterEnding":"2026/03","expectedEps":-0.48,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GENB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GENB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1782360000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GENB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GENB","date":"2026-10-12","current":-3.740557,"percent":0.696774,"low":-11.002825,"twenty":-8.789303,"median":-8.056286,"eighty":-7.544963,"high":-6.883628,"avg":-8.193247,"sd":0.730919,"marketCap":1840573932},"quantilePoints":[{"date":"2026-02-27","current":-10.037721,"twenty":-10.037721,"median":-10.037721,"eighty":-10.037721,"marketCap":2039203216},{"date":"2026-03-06","current":-7.810602,"twenty":-7.936073,"median":-7.722772,"eighty":-7.484376,"marketCap":1586755002},{"date":"2026-03-13","current":-8.331309,"twenty":-7.979988,"median":-7.660036,"eighty":-7.484376,"marketCap":1692538669},{"date":"2026-03-20","current":-7.710225,"twenty":-7.979988,"median":-7.68513,"eighty":-7.484376,"marketCap":1566362970},{"date":"2026-03-27","current":-8.061545,"twenty":-7.979988,"median":-7.697677,"eighty":-7.484376,"marketCap":1637735082},{"date":"2026-04-02","current":-8.350129,"twenty":-7.996299,"median":-7.697677,"eighty":-7.419131,"marketCap":1696362175},{"date":"2026-04-10","current":-7.233433,"twenty":-7.996299,"median":-7.647489,"eighty":-7.419131,"marketCap":1469500817},{"date":"2026-04-17","current":-7.910979,"twenty":-8.036451,"median":-7.697677,"eighty":-7.419131,"marketCap":1607147034},{"date":"2026-04-24","current":-8.067818,"twenty":-8.0628,"median":-7.732183,"eighty":-7.42164,"marketCap":1639009584},{"date":"2026-05-01","current":-7.923526,"twenty":-8.036451,"median":-7.810602,"eighty":-7.471829,"marketCap":1609696038},{"date":"2026-05-08","current":-8.522653,"twenty":-8.180743,"median":-7.816876,"eighty":-7.489394,"marketCap":1731410980},{"date":"2026-05-15","current":-8.844872,"twenty":-8.266063,"median":-7.84197,"eighty":-7.500687,"marketCap":1971654609},{"date":"2026-05-22","current":-8.039526,"twenty":-8.266063,"median":-7.83256,"eighty":-7.486839,"marketCap":1792130926},{"date":"2026-05-29","current":-7.527711,"twenty":-8.282375,"median":-7.816876,"eighty":-7.489371,"marketCap":1678039615},{"date":"2026-06-05","current":-8.453579,"twenty":-8.282375,"median":-7.810602,"eighty":-7.474106,"marketCap":1884429514},{"date":"2026-06-12","current":-7.435699,"twenty":-8.229473,"median":-7.788352,"eighty":-7.435629,"marketCap":1657528818},{"date":"2026-06-18","current":-7.976268,"twenty":-8.211907,"median":-7.788092,"eighty":-7.435594,"marketCap":1778029753},{"date":"2026-06-26","current":-9.442705,"twenty":-8.343203,"median":-7.810602,"eighty":-7.4449,"marketCap":2104920587},{"date":"2026-07-02","current":-9.488711,"twenty":-8.508838,"median":-7.810602,"eighty":-7.463837,"marketCap":2115175986},{"date":"2026-07-10","current":-9.040154,"twenty":-8.869967,"median":-7.84197,"eighty":-7.484992,"marketCap":2015185848},{"date":"2026-07-17","current":-7.855502,"twenty":-8.85402,"median":-7.855502,"eighty":-7.488094,"marketCap":1751109331},{"date":"2026-07-24","current":-7.953265,"twenty":-8.801131,"median":-7.883241,"eighty":-7.493159,"marketCap":1772902053},{"date":"2026-07-31","current":-8.06828,"twenty":-8.626167,"median":-7.861253,"eighty":-7.503197,"marketCap":1798540550},{"date":"2026-08-07","current":-7.489636,"twenty":-8.522653,"median":-7.910979,"eighty":-7.503197,"marketCap":1780593602},{"date":"2026-08-14","current":-8.114449,"twenty":-8.453579,"median":-7.917253,"eighty":-7.52196,"marketCap":1929137113},{"date":"2026-08-21","current":-8.632737,"twenty":-8.626167,"median":-7.947085,"eighty":-7.52196,"marketCap":2052355451},{"date":"2026-08-28","current":-8.513962,"twenty":-8.702922,"median":-7.964766,"eighty":-7.527711,"marketCap":2024117915},{"date":"2026-09-04","current":-8.821696,"twenty":-8.713719,"median":-7.99352,"eighty":-7.544963,"marketCap":2097278804},{"date":"2026-09-11","current":-8.308807,"twenty":-8.728836,"median":-8.030177,"eighty":-7.546682,"marketCap":1975343990},{"date":"2026-09-18","current":-9.242805,"twenty":-8.750431,"median":-8.056286,"eighty":-7.554594,"marketCap":2197393704},{"date":"2026-09-25","current":-8.632737,"twenty":-8.845636,"median":-8.06828,"eighty":-7.565666,"marketCap":2052355451},{"date":"2026-10-02","current":-7.450392,"twenty":-8.826331,"median":-8.077459,"eighty":-7.565666,"marketCap":1771263616},{"date":"2026-10-09","current":-7.55297,"twenty":-8.795782,"median":-8.061545,"eighty":-7.541513,"marketCap":1795650579},{"date":"2026-10-12","current":-7.741929,"twenty":-8.789303,"median":-8.056286,"eighty":-7.544963,"marketCap":1840573932}],"updateTime":1791964583551},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GENB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675367910","title":"Generate Biomedicines, Zealand Pharma enter protein therapeutics pact","url":"https://stock-news.laohu8.com/highlight/detail?id=2675367910","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675367910?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:40","pubTimestamp":1791924023,"startTime":"0","endTime":"0","summary":"Generate Biomedicines (GENB) announced a multi-target strategic collaboration with Zealand Pharma (ZLDPF). Under the collaboration, the companies i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/generate-biomedicines-zealand-pharma-enter-protein-therapeutics-pact-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/generate-biomedicines-zealand-pharma-enter-protein-therapeutics-pact-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZLDPF","GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675678923","title":"Zealand Pharma Partners with Generate Biomedicines on AI-Designed Protein Therapeutics for Metabolic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2675678923","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675678923?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:31","pubTimestamp":1791923478,"startTime":"0","endTime":"0","summary":"Zealand Pharma partners with Generate Biomedicines on AI-designed protein therapeutics for metabolic diseasesZealand Pharma entered a collaboration and license agreement with Generate Biomedicines to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDLfQryV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4588","NDAQ","SG9999014039.USD","IE00BQXX3F31.USD","BK4585","SG9999014021.USD","LU2210149790.SGD","BCDF","LU0314104364.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BN0W2V16.EUR","BK4139","GENB","LU2210150020.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675620273","title":"Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2675620273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675620273?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:30","pubTimestamp":1791923400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9HZTZP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362077","title":"Generate Biomedicines - to Receive $30 Mln Upfront, up to $1.20 Bln in Milestones, Plus Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675362077?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:30","pubTimestamp":1791923400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9HZTZP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362075","title":"Generate Biomedicines - Co to Lead Research; Zealand Pharma to Handle Clinical Development and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362075","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675362075?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:30","pubTimestamp":1791923400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9HZTZP:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362022","title":"Generate Biomedicines - to Lead Research; Zealand Pharma to Handle Clinical Development and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362022","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675362022?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:30","pubTimestamp":1791923400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nTUA9HZTZP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362055","title":"Zealand Pharma, Generate Strike Obesity Drug Deal Worth up to $1.2 Billion, Bloomberg News Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362055","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675362055?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:27","pubTimestamp":1791923227,"startTime":"0","endTime":"0","summary":"Zealand Pharma, Generate strike obesity drug deal worth up to $1.2 billion, Bloomberg News reportsOct 13 (Reuters)-Danish drugmakerZealand PharmaZELA.COand Generate BiomedicinesGENB.Ohave struck a dea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nL4N45Z225:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362944","title":"Zealand Pharma Makes Deal with Generate Worth up to $1.2 Billion - Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675362944?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:13","pubTimestamp":1791922436,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nFWN45Z0X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673014287","title":"Generate Biomedicines Price Target Maintained with a $30.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2673014287","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673014287?lang=en_us&edition=fundamental","pubTime":"2026-10-05 18:47","pubTimestamp":1791197220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GENB/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714491","title":"Seven new option listings on October 2nd","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714491","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714491?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:36","pubTimestamp":1790944564,"startTime":"0","endTime":"0","summary":"New option listings for October 2nd include Generate Biomedicines Inc (GENB), Guggenheim Total Return Bond Fund (GTO), Host Digital Inc. (HOST), Ka...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seven-new-option-listings-on-october-2nd-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seven-new-option-listings-on-october-2nd-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US3Y.BOND","US10Y.BOND","TMF","HOST","BK4139","US5Y.BOND","US6M.BOND","US2Y.BOND","US12M.BOND","BK4113","TLT","US7Y.BOND","GENB","GTO","TLTW","US30Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672190737","title":"Analysts Are Bullish on Top NA Stocks: Generate Biomedicines, Inc. (GENB), Netskope, Inc. (NTSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672190737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672190737?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:30","pubTimestamp":1790940611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Generate Biomedicines, Inc. (GENB) and Netskope, Inc. (NTSK)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-generate-biomedicines-inc-genb-netskope-inc-ntsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-generate-biomedicines-inc-genb-netskope-inc-ntsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GENB","BK4097","NTSK","NA","BK4141","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672894751","title":"Generate Biomedicines - Gb-5267 Targets Muc16 Biomarker in over 80% of Ovarian Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672894751","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672894751?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA8HCRWG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759712","title":"Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ Car T Therapy for Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759712?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA8HCRWG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751891","title":"Generate Biomedicines - Gb-5267 Treatment Designed to Avoid Pre-Infusion Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751891?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA8HCRWG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371585","title":"Generate Biomedicines Price Target Maintained with a $30.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371585","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371585?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:05","pubTimestamp":1788883500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GENB/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322443","title":"Generate Biomedicines Management to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322443","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322443?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:09","pubTimestamp":1788865761,"startTime":"0","endTime":"0","summary":"Generate Biomedicines management to present at upcoming investor conferencesGenerate Biomedicines management will present at investor conferences in New York in September.Cantor Global Healthcare Conf","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL7930Tg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG1179.USD","LU0251131958.USD","IE0002270589.USD","IE0004086264.USD","SG9999014039.USD","LU0106831901.USD","GENB","IE00B3QW5Z07.USD","LU0868494708.USD","LU2237443895.HKD","LU1144417596.USD","GSX","IE00BN0W2T93.GBP","SG9999014013.SGD","LU2265009873.SGD","SG9999014021.USD","LU2237443382.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4588","IE00BQXX3C00.GBP","BK4552","LU1894683348.USD","LU1868837136.USD","IE00BQXX3F31.USD","LU2210149790.SGD","LU2471134796.USD","LU1868837300.USD","LU0345770308.USD","LU2210150020.SGD","LU2750360641.GBP","LU1868836591.USD","BK4139","LU0742534661.SGD","BCDF","LU0251142724.SGD","BK4533","LU2237443465.HKD","LU0345770993.USD","LU1791807156.HKD","BK4504","LU0868494617.USD","LU0096364046.USD","NDAQ","LU2896262040.SGD","LU1894683264.USD","LU0314104364.USD","LU2471134952.CNY","IE00BGHQF748.EUR","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664097618","title":"Generate Biomedicines Director Frances Arnold Sells USD 16,002 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664097618","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664097618?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465953,"startTime":"0","endTime":"0","summary":"Generate Biomedicines director Frances Arnold sells USD 16,002 of common sharesGenerate Biomedicines director Frances Arnold sold 1,000 common shares on Sep. 1, 2026 at USD 16.Direct holdings fell to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLbkSFGl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Generate Biomedicines Director Frances Arnold Sells USD 16,002 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706183","title":"Generate Biomedicines is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706183","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706183?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:17","pubTimestamp":1787912220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GENB/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662905727","title":"U.S. Research Roundup-Dollar General, Palo Alto, Workday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662905727","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662905727?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:12","pubTimestamp":1787904773,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Dollar General, Palo Alto, WorkdayAug 28 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Dollar Gene","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0JD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PANW","UMBF","CRWD","P","HPQ","DLTR","NVDW","NVDQ","CRM","JAZZ","RBRK","KFY","CRMG","AVNW","GAP","A","MBRX","ADSK","THFF","BURL","THC","AFRM","ALL","TTXU","ULTA","MRNA","RJF","PALU","NVDY","HEI","NVDA","BBW","CHH","BBY","IGV","3NVD.UK","MLM","DG","AVAH","AXTA","DY","KR","MRVL","HAKY","GENB","CBSH","CUE","MISL","TOL","FSLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662441897","title":"Small U.S. Stocks Finish Mixed as Abercrombie & Fitch Leads, Generate Biomedicines Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2662441897","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662441897?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:21","pubTimestamp":1787775660,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Wednesday, as the Russell 2000 Index fell 0.1%, while the S&P Small Cap 600 Index was up 0.1%.Among companies with a market value of $1 billion to $6.7 billion, Generate Biomedicines Inc. was the biggest laggard during the session, dropping 21%, followed by shares of Evolution Metals & Technologies Corp., which dropped 15%. Shares of Advasa Holdings Inc. dropped 14%, Climb Bio Inc. shares tumbled 9.9%, and Horizon Quantum Holdings Ltd. tumbled 8.9%.Abercrombie & Fitch Co. was the best performer, surging 36%, followed by Biohaven Ltd., which surged 18%. Seaport Therapeutics Inc. shares surged 12%, WEBTOON Entertainment Inc. surged 11%, and shares of SolarEdge Technologies Inc. jumped 11%.Major stock indexes in the U.S. ended Wednesday mixed with the Nasdaq Composite Index dropping 0.1%. Meanwhile, the S&P 500 Index was flat, and the Dow Jones Industrial Average dropped 0.2%.Data ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB","BK4094","BK4588","BK4585","BK4139","ANF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":51,"code":"91000000","status":"200"}]}}